NEW YORK STATE COMMON RETIREMENT FUND - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$241,000
+8.6%
76,4000.0%0.00%
Q2 2020$222,000
+3.3%
76,4000.0%0.00%
Q1 2020$215,000
-13.3%
76,4000.0%0.00%
Q4 2019$248,000
-5.3%
76,400
-37.1%
0.00%
Q3 2019$262,000
-31.2%
121,4000.0%0.00%
Q2 2019$381,000
-15.7%
121,4000.0%0.00%
-100.0%
Q1 2019$452,000
+28.4%
121,4000.0%0.00%0.0%
Q4 2018$352,000
-13.7%
121,400
-21.7%
0.00%
Q3 2018$408,000
-4.9%
155,100
-15.4%
0.00%
-100.0%
Q2 2018$429,000
-20.4%
183,3670.0%0.00%0.0%
Q1 2018$539,000
+7.4%
183,3670.0%0.00%0.0%
Q4 2017$502,000
-4.6%
183,367
+18.2%
0.00%0.0%
Q3 2017$526,000
+37.3%
155,1000.0%0.00%0.0%
Q2 2017$383,000
+8.8%
155,100
-0.0%
0.00%
Q1 2017$352,000
+7.0%
155,101
+0.0%
0.00%
Q4 2016$329,000
-36.7%
155,1000.0%0.00%
-100.0%
Q3 2016$520,000
+6.8%
155,1000.0%0.00%0.0%
Q2 2016$487,000
-5.6%
155,1000.0%0.00%0.0%
Q1 2016$516,000
-6.0%
155,1000.0%0.00%0.0%
Q4 2015$549,000
-29.6%
155,1000.0%0.00%0.0%
Q3 2015$780,000
-68.0%
155,100
-59.1%
0.00%
-75.0%
Q2 2015$2,440,000
-23.2%
379,544
-16.0%
0.00%
-20.0%
Q1 2015$3,177,000
-37.1%
451,613
-31.1%
0.01%
-28.6%
Q4 2014$5,052,000
+36.5%
655,285
+32.2%
0.01%
+16.7%
Q3 2014$3,701,000
+165.9%
495,500
+244.6%
0.01%
+200.0%
Q2 2014$1,392,000143,8000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
Freedom Investment Management, Inc. 54,735$135,0000.02%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
View complete list of PDL BIOPHARMA INC shareholders